DE69631059D1 - Standard zur blutkontrolle - Google Patents

Standard zur blutkontrolle

Info

Publication number
DE69631059D1
DE69631059D1 DE69631059T DE69631059T DE69631059D1 DE 69631059 D1 DE69631059 D1 DE 69631059D1 DE 69631059 T DE69631059 T DE 69631059T DE 69631059 T DE69631059 T DE 69631059T DE 69631059 D1 DE69631059 D1 DE 69631059D1
Authority
DE
Germany
Prior art keywords
standard
sedimentation rate
control
blood control
precision
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69631059T
Other languages
English (en)
Inventor
R Hengstenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hematronix Inc
Streck Inc
Original Assignee
Hematronix Inc
Streck Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hematronix Inc, Streck Laboratories Inc filed Critical Hematronix Inc
Application granted granted Critical
Publication of DE69631059D1 publication Critical patent/DE69631059D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/04Investigating sedimentation of particle suspensions
    • G01N15/05Investigating sedimentation of particle suspensions in blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/22Dextran
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00Reference solutions for assays of biological material
    • G01N2496/05Reference solutions for assays of biological material containing blood cells or plasma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
DE69631059T 1995-10-04 1996-09-27 Standard zur blutkontrolle Expired - Lifetime DE69631059D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/538,959 US5888822A (en) 1995-10-04 1995-10-04 Erythrocyte sedimentation rate control
PCT/US1996/015628 WO1997013146A1 (en) 1995-10-04 1996-09-27 Blood control standard

Publications (1)

Publication Number Publication Date
DE69631059D1 true DE69631059D1 (de) 2004-01-22

Family

ID=24149161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69631059T Expired - Lifetime DE69631059D1 (de) 1995-10-04 1996-09-27 Standard zur blutkontrolle

Country Status (5)

Country Link
US (4) US5888822A (de)
EP (1) EP0853761B1 (de)
AT (1) ATE256286T1 (de)
DE (1) DE69631059D1 (de)
WO (1) WO1997013146A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US5888822A (en) 1995-10-04 1999-03-30 Hycor Biomedical Inc. Erythrocyte sedimentation rate control
US5895760A (en) 1997-02-04 1999-04-20 Hycor Biomedical, Inc. Erythrocyte sedimentation rate control
US6159682A (en) * 1999-04-30 2000-12-12 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6124089A (en) 1999-04-30 2000-09-26 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6531321B1 (en) 2000-09-15 2003-03-11 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US7531357B2 (en) * 2005-04-04 2009-05-12 Bio-Rad Laboratories, Inc. Preparation of platelet analogs
FR2940348B1 (fr) * 2008-12-18 2011-01-21 Spcm Sa Amelioration de la recuperation assistee du petrole par polymere sans equipement ou produit complementaire.
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
ES2891555T3 (es) 2014-06-10 2022-01-28 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
EP4242628A3 (de) 2015-12-08 2023-11-08 Biomatrica, INC. Verringerung der erythrozytensedimentationsrate
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2102785A (en) * 1935-10-18 1937-12-21 Brooks Clyde Method of and apparatus for sedimentation testing of blood
US2929764A (en) * 1951-11-08 1960-03-22 Hultin Eskil Alexis Dextran glucosides, preparation thereof, and blood substitutes containing the same
US2727838A (en) * 1952-11-15 1955-12-20 Commercial Solvents Corp Process for hydrolyzing dextran
US2848368A (en) * 1953-08-20 1958-08-19 Witt Horst Method of measuring blood sedimentation rate
US3660037A (en) * 1970-08-10 1972-05-02 Kurt Rudolf Sokol Device for measuring blood sedimentation rate
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US3962125A (en) * 1975-01-13 1976-06-08 Coulter Diagnostics, Inc. Multi-purpose diluent for use in blood analysis by electronic instrumentation of the coulter type
CA1055932A (en) * 1975-10-22 1979-06-05 Hematech Inc. Blood substitute based on hemoglobin
US4264470A (en) * 1979-05-07 1981-04-28 Coulter Electronics, Inc. Selecting goat erythrocytes to simulate human platelets in hematologic reference controls
US4358394A (en) * 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4299726A (en) * 1979-05-07 1981-11-10 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor
US4324686A (en) * 1979-06-11 1982-04-13 R & D Systems, Inc. Hematology control composition and methods for its use
US4489162A (en) * 1981-12-21 1984-12-18 American Hospital Supply Corporation Fresh blood (unfixed) hematology control
US4436821A (en) * 1982-04-12 1984-03-13 Streck Laboratories, Inc. Simulated human platelets from red blood cells
DE3225408A1 (de) * 1982-07-07 1984-01-12 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Waessrige loesung zum suspendieren und lagern von zellen, insbesondere erythrozyten
US4704364A (en) * 1984-05-18 1987-11-03 Coulter Electronics, Inc. Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US5328822A (en) * 1990-04-23 1994-07-12 Solid State Farms, Inc. Apparatus and method for sedimentation based blood analysis
DE4117583A1 (de) * 1991-05-29 1992-12-03 Helmut Prof Dr Orth Geraet zur messung der blutsenkung
BR9305960A (pt) * 1992-02-24 1997-10-21 Coulter Corp Produto de controle de hematologia e processo para utilizar meio de suspensão de célula
US5397479A (en) 1993-04-26 1995-03-14 International Remote Imaging Systems, Inc. Composition and method for enrichment of white blood cells from whole human blood
US5888822A (en) 1995-10-04 1999-03-30 Hycor Biomedical Inc. Erythrocyte sedimentation rate control
US5895760A (en) * 1997-02-04 1999-04-20 Hycor Biomedical, Inc. Erythrocyte sedimentation rate control
US5894760A (en) 1997-06-12 1999-04-20 Brooks Automation, Inc. Substrate transport drive system
US6159682A (en) * 1999-04-30 2000-12-12 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement
US6124089A (en) * 1999-04-30 2000-09-26 Streck Laboratories, Inc. Blood control and system for erythrocyte sedimentation measurement

Also Published As

Publication number Publication date
EP0853761B1 (de) 2003-12-10
US5888822A (en) 1999-03-30
US6331435B1 (en) 2001-12-18
ATE256286T1 (de) 2003-12-15
EP0853761A1 (de) 1998-07-22
US6051433A (en) 2000-04-18
WO1997013146A1 (en) 1997-04-10
US5863799A (en) 1999-01-26
EP0853761A4 (de) 1999-06-02

Similar Documents

Publication Publication Date Title
ATE256286T1 (de) Standard zur blutkontrolle
KR950700539A (ko) 백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use)
PT97666A (pt) Aparelho para preparar um concentrado de factores de coagulacao a partir de uma amostra de sangue
ES8609719A1 (es) Una suspension fluida de control de referencia para hemato- logia
Van den Besselaar et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system
DE69739565D1 (de) Hämatologische referenzkontrolle und verfahren zur herstellung
DE3587724D1 (de) Antikörper verwendende diagnostische Methoden.
Schreiber et al. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement
DE69417017D1 (de) Antikoagulierende zusammensetzung
Stingl et al. In situ identification of lymphoreticular cells in benign and malignant infiltrates by membrane receptor sites
Rivera et al. HLA antigens on red cells. Implications for achieving low HLA antigen content in blood transfusions
Linch et al. Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.
Kazal et al. The measurement of erythropoietin
AU6366686A (en) Methods and reagents for performing subset analysis
Streichman et al. Moving boundary electrophoresis and sialic acid content of normal and polycythaemic red blood cells
Day et al. Report of the working party on platelets
Dahlgren et al. Chemotactic factor binding and functional capacity: A comparison between human granulocytes and differentiated HL‐60 cells
ES2151895T3 (es) Procedimiento para la obtencion de cultivos celulares con alto contenido en citoquinas endogenas.
Issaragrisil Correlation between hematopoietic progenitors and erythroblasts in cord blood
Walter et al. Separation of human rosette-and nonrosette-forming lymphoid cells by countercurrent distribution in an aqueous two-phase system
Serke et al. European survey of the flow cytometric determination of CD34-expressing cells
Thompson et al. Platelet Volume Measurements: The Importance Of Anticoagulation
Poggi et al. Stimulation Of DNA Synthesis In Mouse Fibroblasts By Purified Porcine Platelet Secreted Proteins
RU94043381A (ru) Способ прогнозирования течения псориатического артрита
Ponder et al. Protein concentration in normal mouse lymphocytes, thymocytes, and mouse and human leukemic cells as measured by interference microscopy

Legal Events

Date Code Title Description
8332 No legal effect for de